share_log

15 Analysts Assess Axsome Therapeutics: What You Need To Know

15人のアナリストがアクサムセラピューティクスを評価:あなたが知る必要があること

Benzinga ·  06/05 11:01

Throughout the last three months, 15 analysts have evaluated Axsome Therapeutics (NASDAQ:AXSM), offering a diverse set of opinions from bullish to bearish.

The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.

BullishSomewhat BullishIndifferentSomewhat BearishBearish
Total Ratings96000
Last 30D01000
1M Ago31000
2M Ago02000
3M Ago62000

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $137.8, a high estimate of $190.00, and a low estimate of $106.00. Witnessing a positive shift, the current average has risen by 7.07% from the previous average price target of $128.70.

price target chart

Breaking Down Analyst Ratings: A Detailed Examination

An in-depth analysis of...

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする